BCPC vs SHC
BCPC: Balchem is a specialty chemicals and nutrition ingredients manufacturer serving human nutrition, animal feed, food systems, and industrial sterilization markets with microencapsulation and chelation technologies. SHC: A global sterilization and lab testing partner ensuring the safety of medical devices and pharmaceuticals for 40+ top-50 device makers and 9 of top-10 pharma companies.
Side-by-side fundamentals
| Metric | BCPC | SHC | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $164.79 | $17.24 | |
| Market cap as of 2026-07-29 | $5.3B | $4.9B | |
| P/E as of 2026-07-29 | 33.84 | 42.02 | BCPC lower |
| PEG as of 2026-07-29 | 2.04 | 3.82 | BCPC lower |
| Net margin as of 2026-07-29 | +14.9% | +9.9% | BCPC higher |
| Gross margin as of 2026-07-29 | +36.3% | +55.3% | SHC higher |
| Operating margin as of 2026-07-29 | +20.2% | +29.0% | SHC higher |
| ROE as of 2026-07-29 | +12.4% | +20.6% | SHC higher |
| ROA as of 2026-07-29 | +9.4% | +3.6% | BCPC higher |
| Debt / equity as of 2026-07-29 | 0.13 | 3.59 | BCPC lower |
| Revenue growth (YoY) as of 2026-07-29 | +9.6% | +7.4% | BCPC higher |
| Revenue CAGR (3y) SEC XBRL | +3.2% | +5.1% | SHC higher |
| Dividend yield as of 2026-07-29 | +0.6% | n/a | |
| Dividend streak (yrs) SEC XBRL | 4 | n/a | |
| Beta as of 2026-07-29 | 0.82 | 1.78 | |
| 1-year return as of 2026-07-27 close | +10.7% | +40.2% | SHC higher |
Fundamentals: Finnhub, as of 2026-07-29. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.